Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IDEXX Laboratories, Inc. (IDXX : NSDQ)
 
 • Company Description   
IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Number of Employees: 11,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $536.34 Daily Weekly Monthly
20 Day Moving Average: 456,326 shares
Shares Outstanding: 80.42 (millions)
Market Capitalization: $43,133.50 (millions)
Beta: 1.54
52 Week High: $546.39
52 Week Low: $356.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 4.18% -0.33%
12 Week 41.52% 15.46%
Year To Date 29.73% 22.97%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
ONE IDEXX DRIVE
-
WESTBROOK,ME 04092
USA
ph: 207-556-0300
fax: 207-556-4346
investorrelations@idexx.com http://www.idexx.com
 
 • General Corporate Information   
Officers
Jonathan J. Mazelsky - President; Chief Executive Officer and Director
Lawrence D. Kingsley - Chairman
Brian P. McKeon - Executive Vice President; Chief Financial Officer
Irene Chang Britt - Director
Bruce L. Claflin - Director

Peer Information
IDEXX Laboratories, Inc. (ABMD)
IDEXX Laboratories, Inc. (DMDS)
IDEXX Laboratories, Inc. (CPWY.)
IDEXX Laboratories, Inc. (EQUR)
IDEXX Laboratories, Inc. (ECIA)
IDEXX Laboratories, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45168D104
SIC: 2835
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 80.42
Most Recent Split Date: 6.00 (2.00:1)
Beta: 1.54
Market Capitalization: $43,133.50 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $3.29 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $12.16 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 11.26% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 44.11
Trailing 12 Months: 49.57
PEG Ratio: 3.92
Price Ratios
Price/Book: 29.79
Price/Cash Flow: 43.15
Price / Sales: 10.97
EPS Growth
vs. Year Ago Period: 5.34%
vs. Previous Quarter: 12.98%
Sales Growth
vs. Year Ago Period: 3.56%
vs. Previous Quarter: 4.63%
ROE
06/30/25 - -
03/31/25 - 57.35
12/31/24 - 55.82
ROA
06/30/25 - -
03/31/25 - 26.97
12/31/24 - 26.48
Current Ratio
06/30/25 - -
03/31/25 - 1.16
12/31/24 - 1.31
Quick Ratio
06/30/25 - -
03/31/25 - 0.81
12/31/24 - 0.95
Operating Margin
06/30/25 - -
03/31/25 - 22.76
12/31/24 - 22.78
Net Margin
06/30/25 - -
03/31/25 - 22.76
12/31/24 - 22.78
Pre-Tax Margin
06/30/25 - -
03/31/25 - 28.60
12/31/24 - 28.48
Book Value
06/30/25 - -
03/31/25 - 18.00
12/31/24 - 19.48
Inventory Turnover
06/30/25 - -
03/31/25 - 3.94
12/31/24 - 3.94
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.31
12/31/24 - 0.28
Debt-to-Capital
06/30/25 - -
03/31/25 - 23.70
12/31/24 - 21.99
 

Powered by Zacks Investment Research ©